Drug Type Small molecule drug, Liposomal Drug |
Synonyms Lipocurc |
Action inhibitors, antagonists |
Mechanism DNMT1 inhibitors(DNA (cytosine-5)-methyltransferase 1 inhibitors), RBM3 inhibitors(RNA binding motif protein 3 inhibitors), TGF-β inhibitors(Transforming growth factor beta inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 1/2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Advanced cancer | Phase 2 | Austria | 01 Mar 2014 | |
Neoplasm Metastasis | Phase 2 | Austria | 01 Mar 2014 |